ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: NHS Greater Clyde and Glasgow
Cancer Research UK
Information provided by: NHS Greater Clyde and Glasgow
ClinicalTrials.gov Identifier: NCT00134108
  Purpose

The purpose of this study is to conduct a formal controlled evaluation of the potential benefits of CBT for insomnia in cancer patients.


Condition Intervention
Insomnia
Cancer
 Behavioral: Cognitive Behaviour Therapy

MedlinePlus related topics:   Cancer   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients

Further study details as provided by NHS Greater Clyde and Glasgow:

Study Start Date:   January 2003
Estimated Study Completion Date:   December 2005

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Criteria

Inclusion Criteria:

  • Meets clinical criteria for insomnia.
  • Diagnosis of breast, prostate, colorectal or gynaecological cancer.
  • In follow-up phase with no further anti-cancer therapy planned.

Exclusion Criteria:

  • Anti-cancer chemotherapy or radiotherapy within 4 weeks of trial entry.
  • Evidence of sleep apnoea or other sleep disorder.
  • Evidence of untreated major depressive disorder.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00134108

Locations
United Kingdom
North Glasgow and Grampian Trusts    
      Glasgow and Aberdeen, United Kingdom

Sponsors and Collaborators
NHS Greater Clyde and Glasgow
Cancer Research UK

Investigators
Principal Investigator:     Colin Espie, PhD     University of Glasgow    
  More Information


Study ID Numbers:   C8265/A3036
First Received:   August 23, 2005
Last Updated:   October 25, 2005
ClinicalTrials.gov Identifier:   NCT00134108
Health Authority:   United Kingdom: National Health Service

Study placed in the following topic categories:
Sleep Initiation and Maintenance Disorders
Mental Disorders
Dyssomnias
Sleep Disorders
Sleep Disorders, Intrinsic

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on October 17, 2008

U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers